Simplex Trading, LLC Imv Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.56 - $1.45 $170 - $440	-304 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.07 - $1.5 $1,512 - $2,121	-1,414 Reduced 82.31%	304 $0
Q4 2021 Feb 23, 2022	SELL	$1.22 - $1.78 $2,527 - $3,688	-2,072 Reduced 54.67%	1,718 $2,000
Q3 2021 Oct 28, 2021	BUY	$1.35 - $2.16 $1,324 - $2,118	981 Added 34.92%	3,790 $8,000
Q2 2021 Aug 12, 2021	SELL	$2.12 - $3.24 $9,819 - $15,007	-4,632 Reduced 62.25%	2,809 $6,000
Q1 2021 Apr 26, 2021	BUY	$2.92 - $4.41 $12,593 - $19,020	4,313 Added 137.88%	7,441 $24,000
Q4 2020 Feb 02, 2021	BUY	$2.9 - $4.4 $8,549 - $12,971	2,948 Added 1637.78%	3,128 $9,000
Q3 2020 Oct 14, 2020	BUY	$2.87 - $5.95 $516 - $1,071	180 New	180 $0

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.